DJO Joint Replacement Growth Driven by New Products

DJO reported 3Q19 orthopedic revenue of USD $97.9 million, +5.9% vs. 3Q18.

Colfax leadership says it is off to a strong start implementing operational efficiencies at DJO through their CBS program
Surgeon conversions and new products like the AltiVate shoulder, EMPOWR Knee and AltiVate Reverse Short Stem drove joint replacement...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us